Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Phase I Clinical Trial News Monitoring

Get by Email • RSS

Published on May 10, 2025

Ananda Pharma on phase I trial progress - ICYMI

Ananda Pharma Plc (AQSE:ANA, OTCQB:ANANF) co-founder and CEO Melissa Sturgess talked with Proactive about the company’s progress towards beginning its first clinical trial in Australia for its cannabinoid-based drug candidate. Sturgess confirmed that the …

Source: Proactive UK - Neutral
Published on May 10, 2025

Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025

Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma CRANBERRY TOWNSHIP, PENNSYLVANIA / ACCESS Newswire / May 9, 2025 / Jabez Biosciences, Inc., a pioneering biotechnology …

Source: European Business Magazine - Indeterminate
Published on May 9, 2025

ARVO 2025: Perfuse Therapeutics announces positive results from phase 1/2a trial of PER-001, an intravitreal implant for ...

Biopharmaceutical company Perfuse Therapeutics has announced positive 24-weeks results from its Phase 1/2a trial of PER-001, a first-in-class endothelin antagonist intravitreal implant for glaucoma.1 Data from the completed trial was presented at the …

Source: Optometry Times - Pending
Published on May 10, 2025

A Bibliometric Analysis of Microneedle-Mediated Drug Delivery: Trends, Hotspots, and Future Directions

Introduction Fast, efficient, and minimally invasive drug delivery methods have long been a focal point of medical research. Oral administration is convenient and non-invasive, but its efficacy is limited by first-pass metabolism, and the bioavailability …

Source: Dove Medical Press - Neutral
Published on May 8, 2025

Bombay HC Issues Notice To CDSCO Over Rejection Of Phase I Cancer Drug Trial Application For Immunotherapy

Bombay High Court issues notice to CDSCO over rejection of cancer drug trial application | Representational Image Mumbai: The Bombay High Court has issued notice to the Central Drugs Standard Control Organisation (CDSCO) and the Union government in a …

Source: Free Press Journal - Neutral
Published on May 8, 2025

Patient centricity and effective designs drive clinical trial success

The aim of the EU Clinical Trials Regulation (CTR) is to harmonise the clinical trial regulation process across 27 countries and have an 80-day approval timeline, stated Dr. Martine Dehlinger-Kremer, vice president of Scientific Affairs at global contract …

Source: Clinical Trials Arena - Pending
Published on May 8, 2025

Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial

Corvus Pharmaceuticals recently announced new interim data for its randomized, double-blind, placebo-controlled phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis (AD) who have failed one prior topical or …

Source: Dermatology Times - Neutral
Published on May 8, 2025

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for ...

Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- UTR Therapeutics Inc (UTRx Inc.), a drug development biotech company based in New York City, USA is pleased to announce a new milestone, the submission of an Investigational New Drug (IND) application to the U.S. …

Distribution channels: Technology ...
Published on May 9, 2025

Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased

Corvus announced new interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis. Shares of Corvus Pharmaceuticals, Inc. (CRVS) traded 30% higher on Friday afternoon after Oppenheimer raised …

Source: Asianet Newsable - Pending
Published on May 8, 2025

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Conference call and webcast on Monday, May 12, 2025, at 2:30 p.m. PT / 5:30 p.m. ET REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a biopharmaceutical company developing novel immunotherapies for the treatment …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 8, 2025

Marengo Doses First Patient in STARt-002 Clinical Trial Evaluating First-in-Class Dual T Cell Agonist, Invikafusp Alfa ...

STARt-002 is a Phase 1b/2 clinical study assessing invikafusp alfa in combination with Gilead’s Trodelvy® for HR+/HER2- and TNBC breast cancer patients across leading U.S. and Canadian breast cancer centers CAMBRIDGE, Mass., May 8, 2025 / …

Source: The AI Journal - Pending
Published on May 9, 2025

A Small Molecule Drug Candidate for Alzheimer’s Treatment

During the 2025 AD/PD International Conference on Alzheimer‘s and Parkinson‘s Diseases and Related Neurological Disorders in Vienna, Galimedix Therapeutics presented pre-clinical data on an oral drug, GAL-201. The data highlight the small molecule’s …

Source: The Medicine Maker - Neutral
Published on May 8, 2025

Transcode Therapeutics Successfully Completes Initial Dosing Of Patients In Cohort 4 Of Phase 1A Clinical Trial No ...

(MENAFN- PR Newswire) 15 patients treated across four escalating dose levels of TTX-MC138 No significant safety or dose limiting toxicities reported 10 patients remain on study with no evidence of disease progression PD analysis at 24 hours post-dosing …

Source: MENAFN - Indeterminate
Published on May 7, 2025

Innovent Biologics completes first patient dosing in its phase 2 clinical trial assessing efdamrofusp alfa in patients ...

Biopharmaceutical company Innovent Biologics has completed the first patient dosing in its phase 2 clinical trial assessing efdamrofusp alfa for the treatment of diabetic macular edema (DME).1 The recombinant human vascular endothelial growth factor …

Source: Optometry Times - Pending
Published on May 7, 2025

Galimedix Therapeutics completes single ascending dose portion of phase 1 trial assessing GAL-101

Phase 2 clinical stage biotechnology company Galimedix Therapeutics has announced the completion of the single ascending dose (SAD) portion of its phase 1 study assessing the GAL-101, an oral therapy designed to treat Alzheimer disease, dry age-related …

Source: Optometry Times - Pending
Published on May 7, 2025

Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson'...

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-reported outcomes Detailed Phase 1/2a trial data will be presented this week at IAPRD 2025 SAN DIEGO and NEW …

Source: WFMZ - Pennsylvania - Neutral
Published on May 8, 2025

Ionctura Commences Randomized Phase I/II Study In Non-Small Cell Lung Cancer

(MENAFN- PR Newswire) First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have progressed on prior immunotherapy/chemo Study will evaluate safety of the combination and explore whether …

Source: MENAFN - Indeterminate
Published on May 7, 2025

Connext Successfully Completes Dose Escalation Part of CNT201 Phase 1/2 Clinical Trial for Dupuytren’s Contracture

– Conducted under U.S. FDA-cleared IND – Plans for Phase 2 initiation in Q3 2025 and expansion into Peyronie’s disease SEOUL, South Korea, May 7, 2025 /PRNewswire/ — Connext, a clinical stage biotechnology company, announced the successful …

Source: The Laotian Times - Indeterminate

01 days 20:02:36

Featured Releases

Got News to Share? · Submit · See All

Published on May 9, 2025 - 10:00 GMT

Florida Governor Ron DeSantis Joins Olympia Pharmaceuticals in Ribbon-Cutting Ceremony for New Sister Pharmacy, Wesley ...

ORLANDO, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- Wesley Pharmaceuticals, a state-of-the-art 503B compounding facility and Olympia Pharmaceuticals' new sister brand, proudly celebrated its grand opening with a ribbon-cutting ceremony and facility tour at …

Distribution channels:
Published on May 10, 2025 - 03:46 GMT

AHA files brief in defense of Nebraska’s 340B contract pharmacy law

The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state’s 340B contract pharmacy law prohibiting drug companies from denying hospitals the same 340B discounts for drugs dispensed at community …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on May 9, 2025 - 10:35 GMT

U.S. 503B Compounding Pharmacies Market Projected To Witness Massive Growth, 2025-2032 | Athenex, Inc., Avella Specialty

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The latest report (2025-2032) on the U.S. 503B Compounding Pharmacies Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 10:29 GMT

GLP-1 Receptor Agonist Market Projected To Witness Substantial Growth, 2025-2032: Sanofi, Novo Nordisk A/S, AstraZeneca

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The GLP-1 receptor agonist market would be worth USD 28.19 billion in 2025 and grow at a compound annual growth rate (CAGR) of 12.3% to reach USD 63.54 billion by 2032. The …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on May 9, 2025 - 15:00 GMT

Silver Nitrate Market to Reach USD 10.29 Billion by 2035, Driven by Growth in Industrial and Pharmaceutical Sectors

The USA leads the silver nitrate market, driven by its pharmaceutical and healthcare sectors, with growing demand in wound care, eyes, and medical coatings. NEWARK, DE, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The silver nitrate market is …

Distribution channels: Chemical Industry ...
Published on May 9, 2025 - 10:03 GMT

Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032: Biocon, Novo Nordisk, Gan & Lee Pharmaceuticals

BURLINGAME, CA, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Global type 1 diabetes market is estimated to be valued at USD 16.97 Bn in 2025 and is expected to reach USD 26.22 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on May 10, 2025 - 02:05 GMT

Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the ...

The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the …

Distribution channels: U.S. Politics
Published on May 9, 2025 - 20:05 GMT

Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates

Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25 On-track to enable dosing ALS patients in late 2025 BOTHELL, Wash., May 09, 2025 ( …

Distribution channels:

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 811,540,544 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 04/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 10, 2025 - 20:00 GMT

First 5 California and First 5 San Diego Announce Stronger Starts Statewide Day of Action with Family Event

First 5 California and First 5 San Diego hosted a joint event today to commemorate Stronger Starts Statewide Day of Action 2025 SAN DIEGO, CA, UNITED STATES, May 10, 2025 /⁨EINPresswire.com⁩/ -- First 5 California and First 5 San Diego hosted a joint …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 17:57 GMT

California Dispensaries Redefine Cannabis Retail Through Innovation and Community Engagement

818 Brands, Gradus Hollywood, and The Syndicate Tarzana Showcase Distinctive Approaches to Customer Experience and Local Connection LOS ANGELES, CA, UNITED STATES, May 10, 2025 /⁨EINPresswire.com⁩/ -- As California’s cannabis industry continues to …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on May 10, 2025 - 17:26 GMT

Charitable Intentions Inspire Charitable Results at REVEL

REVEL’S Charity Carnaval in 2025 Will Support SickKids Foundation NIAGARA FALLS, ONTARIO, CANADA, May 10, 2025 /⁨EINPresswire.com⁩/ -- The REVEL Charity Carnaval has become a unique, annual tradition, hosted by REVEL REALTY INC. in support of …

Distribution channels: Banking, Finance & Investment Industry, Companies ...
Published on May 10, 2025 - 17:13 GMT

Chronicle Associates Presents: Pursuit of Freedom – A Memoir of Courage and Reinvention

Chronicle Associates Presents: From Tehran to Triumph: Fariba Kalantari’s Inspiring Memoir “Pursuit of Freedom” Chronicles the Journey of Reinvention and Hope HOUSTON, TX, UNITED STATES, May 10, 2025 /⁨EINPresswire.com⁩/ -- Pursuit of Freedom: A …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on May 10, 2025 - 16:41 GMT

Surgeon General's Warning: Social Media Risks Demand Comprehensive Youth Mental Health Support

U.S. Surgeon General warns of social media’s harm to youth mental health, urging action to curb risks like anxiety, depression, and cyberbullying. CA, UNITED STATES, May 10, 2025 /⁨EINPresswire.com⁩/ -- The U.S. Surgeon General’s Advisory on …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 16:00 GMT

The Role of Hair Transplantation in Boosting Self-Esteem and Confidence – Smile Hair Clinic's Expertise

ISTANBUL, TURKEY, May 10, 2025 /⁨EINPresswire.com⁩/ -- Hair loss is a common issue that affects millions of people worldwide, and its impact goes beyond just physical appearance. It can significantly affect one’s self-esteem and confidence, leading …

Distribution channels: Beauty & Hair Care, Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 18:25 GMT

Best Vyvanse Alternative Over the Counter for ADHD - Natural Vyvanse Substitute - Noocube

London, May 10, 2025 (GLOBE NEWSWIRE) -- Vyvanse is a prescription medication that is used to treat ADHD symptoms, but it can be expensive and some people don't like the idea of taking a drug class medicine or stimulant medications. For these reasons …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 16:28 GMT

Akero Therapeutics präsentiert auf dem EASL-Kongress 2025 die Ergebnisse nach 96 Wochen der klinischen Phase-IIb-Studie ...

SOUTH SAN FRANCISCO, Kalifornien, May 10, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), ein in der klinischen Phase tätiges Unternehmen, das bahnbrechende Therapien für Patienten mit schwerwiegenden Stoffwechselkrankheiten entwickelt, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 16:28 GMT

Akero Therapeutics présente les résultats de la 96e semaine de l’essai clinique de phase 2b SYMMETRY sur l’éfruxifermine ...

SOUTH SAN FRANCISCO, État de Californie, 10 mai 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ : AKRO), une société en phase clinique développant des traitements révolutionnaires pour les patients atteints de maladies métaboliques graves et dont …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 15:03 GMT

MEDVi Under Review: Best GLP-1 Semaglutide & Terzepatide Compound Solution for Personalized Weight Loss

New York, May 10, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The growing challenges with traditional weight loss methods and why most diets fail What GLP-1 receptor agonists like Semaglutide and Tirzepatide are and how they support …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 10, 2025 - 12:21 GMT

Sumatra Slim Belly Tonic Reviews: 2025 Real User Reviews Analyzed & Verified (Blue Tonic for Weight Loss)

LOS ANGELES, May 10, 2025 (GLOBE NEWSWIRE) -- Losing weight these days can feel more difficult than ever. Despite trying countless diets, workout routines, and the latest supplements, many people still struggle with stubborn belly fat that just won't …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 9, 2025 - 23:36 GMT

RPM Healthcare Applauds New York’s Medicaid Reimbursement for Remote Patient Monitoring

ST. PETERSBURG, FL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- RPM Healthcare proudly supports New York State Medicaid’s decision to reimburse Remote Patient Monitoring (RPM) services under CPT code 99457, marking a significant advancement …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 23:36 GMT

RPM Healthcare Study on Stage 2 Hypertension Published in The American Journal of Managed Care

ST. PETERSBURG, FL, FL, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- RPM Healthcare is proud to announce the publication of its peer-reviewed study, “Effect of Remote Patient Monitoring on Stage 2 Hypertension,” in The American Journal of …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 11:15 GMT

Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive ...

Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL Congress 65% of patients with clinically significant portal hypertension (CSPH) at baseline moved into lower risk …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 9, 2025 - 22:56 GMT

Nurses Denounce Trump Health Policies to Celebrate Nurses Week

Nursing advocates release statement and video calling for global resistance to Trump Administration’s attacks on public health BALTIMORE, MD, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Hundreds of nurses have signed a statement opposing …

Distribution channels: Environment, Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 22:50 GMT

Less Cancer Calls on Congress to Exercise Compassion as DOGE Cuts Cancer Research and Prevention Initiatives

WASHINGTON, DC, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- Less Cancer, a 501(c)3 charity working to educate the public and create proactive public policies regarding cancer and cancer prevention, is calling on Congress and the public to …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 10, 2025 - 10:08 GMT

6 Best Fat Burners For Women: Top Over the Counter and Online Pills and Fat Burning Supplements For Women Weight Loss In ...

New York City, NY, May 10, 2025 (GLOBE NEWSWIRE) -- It has now been proven scientifically that women may have a harder time losing weight and burning off body fat as compared to men. Doesn’t seem fair, but this is the truth. Why this happens is because of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 09:14 GMT

Best Fat Burners For Men 2025: Top Weight Loss Pills & Supplements For Fast Fat Loss - Wolfson Brands Ltd

New York City, May 10, 2025 (GLOBE NEWSWIRE) -- Introduction: Why Fat Burners Are a Game-Changer for Men in 2025 Losing weight and building a leaner physique are common goals for men in 2025. But even with the best diet and workout routine, shedding …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 10, 2025 - 09:10 GMT

4 Best Supplements for Muscle Growth in 2025 - Legal Steroid Alternatives & Bodybuilding Supplements for Bulking and ...

Glasgow, May 10, 2025 (GLOBE NEWSWIRE) -- The best legal supplements for muscle growth is presented by Wolfson Brands Building serious muscle isn’t just about hitting the gym hard, it’s about giving your body the right supplements to gain muscle size, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 9, 2025 - 20:53 GMT

A groundbreaking discovery of a common master switch to cure Alzheimer’s, Parkinson’s, and other brain-related diseases

A breakthrough that could save millions of lives NEW YORK, NY, UNITED STATES, May 9, 2025 /⁨EINPresswire.com⁩/ -- The 21st edition of Sustainability Through Science and Technology Summit 2025 (SIPS 2025), dedicated to Prof. Aaron Ciechanover, Nobel …

Distribution channels: Chemical Industry, Education ...